Panelists at a virtual congressional briefing, including James Kublin, MD, addressed critical questions about new diagnostic technologies, vaccine and treatment development, and the long-term impact of COVID-19 on patients who have recovered from the disease.
The field of medicine has been plagued by the underrepresentation of African Americans, people of Hispanic heritage, and Native Americans, as well as institutional racism and sexism that have persisted for decades.
Researchers sought to highlight several recent advances in the epidemiology, pathogenesis, clinical features, investigation, acute management, and secondary prevention of cerebrovascular diseases in patients with hematological diseases.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
A group of US-based hemophilia experts summarized unmet needs in mild to moderate hemophilia and provided suggestions for healthcare professionals to optimally manage their patients with this challenging condition.
A year-end update on WM, a distinct entity of lymphoplasmacytic lymphoma presenting with monoclonal pleomorphic immunoglobulin M (IgM) proteins, was recently published in the American Journal of Hematology.
Chimeric antigen receptor (CAR)-T cells can kill off-target tumor cells in the vicinity of the target cells, a phenomenon known as bystander killing. Modulating the expression of the protein mediating this process—Fas—could be a strategy to improve CAR-T efficacy.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
The Office for Civil Rights in the US Department of Health and Human Services announced proposed changes to strengthen patients’ rights to access their own health information, improve care coordination, and reduce regulatory burdens.